INCB000631
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for INCB000631, covering 2025-06-11 to 2025-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult Participants [Phase 1]